[MOL] Multicenter, Phase 11 Trial of Exemestane as 3rd line hormonal t. [00293] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Multicenter, Phase 11 Trial of Exemestane as 3rd line hormonal t. for PMW with Metastatic Breast Cancer.....



Title: Multicenter, Phase II Trial of Exemestane as
  Third-Line Hormonal Therapy of Postmenopausal Women With
  Metastatic Breast Cancer
Abstract: Pharmacia & Upjohn, SpA, Milan, Italy.
  Address reprint requests to Stephen E. Jones, MD, Sammons
  Cancer Center, Baylor University Medical Center, 3535
  Worth St, Dallas, TX 75246 ABSTRACT TOP ABSTRACT
  INTRODUCTION PATIENTS AND METHODS RESULTS DISCUSSION
  APPENDIX REFERENCES PURPOSE: To assess the antitumor
  activity, safety, and hormone-suppressive effects of the
  irreversible aromatase...
Source: Journal of Clinical Oncology
http://webmedlit.silverplatter.com/j/3822dea879/
Warmly, lillian
 
We invite you to take a look at our Album.                                               
www.angelfire.com/sc/molangels/index.html
 
  ( Very informational, good tips, Molers pictures, art work and much more....